In Vitro Antiviral Activity of Green Tea Polyphenon-60 against Avian Paramyxoviruses

Pham, Hang Minh

doi:https://doi.org/10.1155/2021/3411525

Veterinary Medicine International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2021 | Article ID 3411525 | https://doi.org/10.1155/2021/3411525

In Vitro Antiviral Activity of Green Tea Polyphenon-60 against Avian Paramyxoviruses

Hang Minh Pham¹

Academic Editor: Francesca Mancianti

Received31 Jul 2021

Revised23 Oct 2021

Accepted18 Nov 2021

Published06 Dec 2021

Abstract

Avian paramyxoviruses (APMVs) have caused an economically significant drop in global domestic poultry production because of their high morbidity and mortality rates. Polyphenols are the major components of green tea that have great antiviral effects. This study aimed to evaluate the anti-APMV activities of polyphenon-60. Twelve APMV-1 strains representing three different pathotypes, two strains of APMV-2, one strain of APMV-3, and one strain of APMV-7 were propagated in chicken embryos. To determine the cytotoxic effect, chicken embryo fibroblasts were treated with the test compound in various concentrations. To assess the antiviral properties, time-dependent, dose-dependent, and virulence-dependent experiments were conducted in both cell and chicken embryo models. A reduction in virus titers was measured by the hemagglutination test. The inhibitory effect on virus adsorption to the chicken red blood cell (RBC) surface was examined by the hemagglutination inhibition test. The results showed that lentogenic and mesogenic APMV-1 strains, APMV-3 strain, and APMV-7 strain were significantly inhibited () by polyphenon-60 at 50 μg/ml, while the 50% cytotoxic concentration of the compound was 345 μg/ml. Polyphenon-60 also exhibited the inhibitory activity against hemagglutination by NDV. Taken together, the results suggest that polyphenon-60 has shown promise as an antiviral agent that has wide safety margins against APMVs, and challenge studies to evaluate its efficacy in chickens are necessary.

1. Introduction

Avian paramyxoviruses (APMVs) have been detected from a wide variety of avian species worldwide with variable clinical outcomes and economic impacts [1]. Newcastle disease virus (NDV), formally termed avian paramyxovirus serotype-1 (APMV-1), is the one of the twenty-one serotypes that has been officially recognized [2]. NDV strains can be differentiated based on their pathogenicity for chicken inoculation. Highly virulent (velogenic) strains cause acute infections with high mortality, bilateral conjunctivitis, preceded by respiratory and neurological signs, or hemorrhagic lesions in the gut [3]. The intracerebral pathogenicity index (ICPI) values for velogenic strains are greater than 1.5. Moderately virulent (mesogenic) strains with ICPI values ranging from 0.7 to 1.5 cause slight depression, lower mortality rates, and decrease egg production in laying flocks. Low virulent or nonpathogenic (lentogenic) strains may produce only mild respiratory signs in young chickens with very low mortality rates, low reduction in egg production, and ICPI values of less than 0.7 [4].

APMVs are enveloped with a single-stranded, nonsegmented, negative-sense RNA genome ranging from 14.9 to 17.4 kb and encode at least six proteins: nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), hemagglutinin-neuraminidase (HN), and large polymerase (L) [5]. NDV infection is initiated by receptor recognition and binding to the host cell surface, which is followed by fusion mediated by the combined action of the HN protein and the F protein [6, 7]. Despite the fact that vaccination programs provided significant protection against ND outbreaks, the virus remained a potential threat to commercial poultry operations as well as backyard producers due to mutations in virus leading to reduce vaccine efficacy [8]. Thus, natural medicinal products have been considered a complementary eradication measure of this disease in developing countries.

Polyphenols are the major components of green tea that have attracted significant attention in the scientific and consumer community for their health benefits. Catechin (C), epigallocatechin-3-gallate (EGCG), epicatechin gallate (ECG), epigallocatechin (EGC), and epicatechin (EC) are the active ingredients of polyphenols [9]. Various biological and pharmacological activities have used the green tea polyphenols including antioxidant, antitumor, antibacterial, antiviral, and antiparasite activities [9–16]. Many previous studies have reported that the mechanisms of antiviral activity of green tea polyphenols, especially EGCG, involve the stages of viral attachment and genome synthesis [9]. However, the inhibitory effects of green tea polyphenols on the growth of NDV as well as other APMV serotypes have not yet been demonstrated.

Therefore, this study aimed to evaluate the anti-APMV activities of green tea polyphenols (polyphenon-60).

2. Materials and Methods

2.1. Cell Culture, Viruses, and Compounds

Chicken embryo fibroblast (CEF) cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Invitrogen) supplemented with 10% fetal calf serum (FCS), 100 IU/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine at 37°C in a humidified atmosphere containing 5% CO₂. APMV serotypes are listed in Table 1; all were reported previously [17] and were propagated in the allantoic cavity of 10-day-old chicken embryos for making viral stocks. The allantoic fluids were harvested, tested for hemagglutination (HA) activity, and then kept frozen at −80°C until use. Polyphenon-60 extracted from green tea (Sigma Chemical, St. Louis, Mo.) was used in all experiments. The stock solution of 1 mg/ml was prepared in deionized water and was sterilized by passage through a 0.22 μm-pore-size syringe tip filter. The solution was then solubilized in the tissue culture medium for in vitro experiments or in distilled water for in vivo studies.

2.2. Hemagglutinin (HA) and Hemagglutination Inhibition (HI) Assays

The HA assay was conducted to measure the reduction in virus titers. Each well on a V-bottom 96-well plate was dispensed with 25 μl of PBS. Subsequently, 25 μl of the supernatant of infected cells or the infected embryonic fluids was added to each well of the first row on the plate. Two-fold serial dilutions were carried out until the second last well on the plate. The last well was used as a control well and was filled with PBS. Then, 25 μl of 0.5% chicken red blood cell (RBC) suspension was added to each well, and the plate was allowed to keep at room temperature for 45 min. A negative result displayed as a red point at the bottom center of the well, and a positive result was the formation of a diffuse mat on the bottom of the well. The virus titers were displayed as HA units and were determined as the inverse of the virus last dilution showing complete agglutination.

The HI assay was conducted to examine the inhibitory effect of polyphenon-60 on virus adsorption to the chicken RBC surface and was performed as described for NDV [18]. In brief, 25 μl (4 HAU) NDV was mixed with 25 μl of polyphenon-60 at different concentrations in a V-bottomed 96-well plate at room temperature for 30 min. This mixture was subsequently incubated with 50 μl of 0.5% chicken RBCs at room temperature for 45 min. The inhibition hemagglutination of polyphenon-60 was observed after the incubation period. The virus in the absence of polyphenon-60 was used as a negative control, and PBS was used as a positive control.

2.3. 50% Tissue Culture Infectious Dose and 50% Embryo Infectious Dose

PBS was used to prepare eight 10-fold serial dilutions of a viral stock. The TCID₅₀ assay was performed using the confluent CEF monolayers. Each well of a 96-well flat-bottom plate was inoculated with 20 μl dilution. After 1 hour for viral infection, the supernatant was replaced with 100 μl of DMEM containing 5% FBS. To monitor the cytopathic effect (CPE), the plate was incubated for 5 days at 37°C. The EID₅₀ assay was performed using 9-day-old SPF chicken embryos. Each of the five embryonic eggs was inoculated with 0.1 ml each dilution and incubated for four days. After the incubation period, all eggs were tested for the presence of HA activity. The TCID₅₀ and EID₅₀ titrations were calculated using the Reed–Muench method [19].

2.4. Cytotoxicity Assay

The cytotoxic concentration (CC) of polyphenon-60 was evaluated using the alamarBlue assay. Each well of the subconfluent monolayer CEF cell on a flat-bottom 96-well plate was washed three times with PBS and treated with 100 μl of serum-free medium with varying concentrations of polyphenon-60 or left untreated for the control. Each concentration was performed three times. The cells were incubated at 37°C for 48 hours to allow for proliferation and were then stained with 10% alamarBlue (Serotec, Oxon, UK) for 4 hours at 37°C in the dark. Reduction of alamarBlue was measured at wavelengths of 562 nm and 595 nm in a microplate reader MTP-650FA (Corona Electric, Hitachinaka, Japan). The percentage reduction (PR) was calculated using the manufacturer’s formula: [A_LW − (A_HW × R₀) for test well/A_LW − (A_HW × R₀) for the control well] × 100. The correction factor (R₀) was calculated with the following formula: R₀ = AO_LW/AO_HW. The CC₅₀ value was determined using linear regression analysis.

2.5. Dose- and Virulence-Dependent Assays

Confluent CEF monolayers on a 48-well flat-bottom plate were infected with a strain at 100 TCID₅₀ and were incubated for 1 hour at 37°C. The cells were washed three times with PBS for removing nonabsorbed virus and were treated with the medium containing the desired concentration of polyphenon-60. Each concentration was performed in triplicate. The induction of CPE in the host cells was observed daily. After 48 hours of incubation, the alamarBlue assay was performed as described above. A well without virus served as a positive control indicating 100% inhibition of CPE. A well with viral infection served as a negative control indicating 0% inhibition. The percent inhibition of CPE was calculated using the following formula: (PR value_{drug treated} − PR value_{negative control})/(PR value_{positive control} − PR value_{negative control}) × 100 [20].

2.6. In Vitro Antiviral Activity

Twelve APMV-1 strains representing three different pathotypes, two strains of APMV-2, one strain of APMV-3, and one strain of APMV-7 were propagated in chicken embryos. Confluent CEF monolayers on a 96-well flat-bottom plate were inoculated with a virus strain at 4 HA units (HAU)/25 μl and were incubated at 37°C for 1 h. After washing three times with PBS, the cells were overlaid with the medium containing varied concentrations of polyphenon-60 and incubated for 48 hours. The supernatants were harvested, and the viral titers were determined by the HA assay.

2.7. In Ovo Antiviral Activity

Each concentration (20 μg/ml and 50 μ/ml) of polyphenon-60 was mixed with an equal volume of the NDV at 100 EID₅₀. Each of the virus-compound mixtures was then inoculated into five 10-day-old chicken embryos. A negative embryo was incubated with the virus and PBS. A positive embryo was incubated with PBS only. Embryo viability was examined daily. Embryo death was recorded as the signs of a breakdown of visible blood vessels of the CAM, blood leakage into the yolk or the allantoic fluid areas, the appearance of disseminated coagulation, and the absence of embryonic movement, and the egg was refrigerated overnight. Up to 24 hours, any dead embryo was discarded. Each allantoic fluid was harvested, and the presence of NDV in the allantoic fluid was tested by the HA assay. The survival rates of embryos were recorded on day 5 (120 h) after inoculation.

2.8. Time-of-Addition Assay

A time-of-addition assay was conducted to investigate the antiviral effects of polyphenon-60 on different stages of the viral infection. Confluent CEF monolayers in a flat-bottom 96-well plate were infected with the NDV B1 strain at 100 TCID₅₀. Polyphenon-60 at 50 μg/ml was added to the cells in different time intervals: at 1 hour prior to infection (preinfection), at the time of infection (infection), and 1 hour, 6 hours, and 12 hours after viral infection (postinfection). The virus-compound mixture was incubated for 48 hours at 37°C. The inhibition effect of polyphenon-60 was evaluated using the alamarBlue assay as described earlier.

2.9. Statistical Analysis

Data were expressed as the mean ± SD of three independent experiments. The differences between the means were analyzed by using Student’s t-test. Statistical significance was considered as values < 0.05.

3. Results

3.1. Cytotoxicity of Polyphenon-60

The cytotoxicity of polyphenon-60 was performed using subconfluent monolayer CEF cells and was measured using the alamarBlue assay. At low concentrations, 10 μg/ml to 100 μg/ml showed the percentage of cell viability was more than 90%, while the concentrations above 400 μg/ml led to reductions of more than 50% cell viability (Figure 1). The CC₅₀ value estimated using regression analysis was 345 μg/ml.

3.2. Antiviral Activity

NDV strains with three different pathotypes included velogenic strain (NDV/Miyadera/51), mesogenic strain (NDV/Komarov/40), and lentogenic strain (NDV/Ishii/62) at 100 TCID₅₀, and polyphenon-60 at different concentrations (0 μg/ml, 20 μg/ml, 50 μg/ml, 100 μg/ml, and 200 μg/ml) was prepared. The antiviral activity was evaluated using the dose- and virulence-dependent assays and was measured using the alamarBlue assay. The CEF cells infected with NDV in the presence or absence of polyphenon-60 showed a differential reduction of virus-induced CPE (Figure 2(a)). The mesogenic and velogenic virus-infected cells were treated with the compound at 50 μg/ml which showed less extensive CPE than those untreated cells. The lentogenic virus-infected cells were treated with the same concentration showing cell morphology similar to control cells (uninfected cells). The highest percentage inhibited by the lentogenic strain was 79% at the concentration of 50 μg/ml. At the lowest concentration of 20 μg/ml, the inhibition ratio was less than 50%. Significant inhibition ratios were also found in the infected cells treated with polyphenon-60 at concentrations of 100 μg/ml and 200 μg/ml. However, in the same concentrations, the maximum inhibition ratios of mesogenic and velogenic strains were only ≈32% and 20%, respectively (Figure 2(b)).

(a)

(b)

To further investigate whether polyphenon-60 could prevent other APMV replications, CEF cells were inoculated with APMV type-1 representing three pathotypes (velogenic, mesogenic, and lentogenic), -2, -3, and -7 at 8 HA units (HAU)/50 μl and were treated with different concentrations at 0 mg/ml, 20 mg/ml, 50 mg/ml, and 100 mg/ml. High doses of polyphenon-60 exhibited a significant reduction of viral HA titers (log₂ HAU) in the cells infected with two lentogenic strains (NDV/Hitcher B1/48 and NDV/Ishii/62), three mesogenic strains (NDV/Komarov/40, NDV/Tochigi/95, and NDV/Kumamoto/2000), and APMV-3 and APMV-7 strains. The same doses showed a light reduction of viral HA titers in the cells infected with velogenic (NDV/Sato/30 and NDV/Taka/73) and two APMV-2 strains. However, the viral HA titers of the cells infected with velogenic NDV strains (NDV/Niigata/85, NDV/Tokyo/96, NDV/Ibaraki-2/99, and NDV/Chiba/2001) were similar to those in untreated cells (Table 1).

3.3. In Ovo Antiviral Activity

To expand on the finding, the egg models were used to evaluate the antiviral activity of polyphenon-60. The results showed that polyphenon-60 extended the time and increased the rate of embryo survival. All untreated embryos that were infected with the velogenic (NDV/Miyadera/51) strain died within 48 hours. The percent survival at 60 and 72 hours after treatment was only 20%. The embryos infected with the mesogenic (NDV/Komarov/40) strain did not survive beyond 72 and 84 hours after treatment. In contrast, all embryos infected with the lentogenic (NDV/Ishii/62) strain and treated with 50 μg/ml of polyphenon-60 survived until day 5 (120 hours) after inoculation (Table 2).

3.4. Time-Dependent Inhibitory Effects

In order to determine the stage of the NDV life cycle blocked by polyphenon-60, the time-of-addition assay was conducted. As shown in Figure 3, the highest inhibition rate of the compound was 80% at 0 h p.i. The inhibition rates reduced to less than 50% when polyphenon-60 was added at 6 h p.i and 12 h p.i. In pretreated cells, the compound’s inhibition rate was only 17%. These results suggested that polyphenon-60 affected the early stages of the virus life cycle.

3.5. Hemagglutination Inhibition of Polyphenon-60

To determine the inhibitory effect of polyphenon-60 on virus adsorption to the chicken RBC surface, the HI test was performed. At all concentration tests, polyphenon-60 completely inhibited HA activity of the NDV/Ishii/62 (lentogenic) strain. No hemagglutination occurred after polyphenon-60 at the highest concentration (50 μg/ml) was mixed with the NDV/Komarov/40 (mesogenic) and the NDV/Miyadera/51 (velogenic) strains (Figure 4). These results suggested that polyphenon-60 might attach to the virus and prevent the virus-RBC binding that inhibits hemagglutination.

4. Discussion

APMV infections continue to emerge as a disease threat in both turkeys and chickens [21]. The options for preventing AMPV transmission included applying adequate biosecurity measures, placing restrictions on movements of birds, quarantining suspected flock, culling infected birds, and using vaccinations. However, backyard poultry production systems with low biosecurity measures, deficient vaccines, antigenic variation, the short duration of the immune response, and immune suppression resulted in the persistence of virulent NDV in the flock and the environment [22]. Therefore, the development of effective antiviral compounds combined with a vaccination program has a positive impact on the prevention and control of APMV.

Many previous studies used epigallocatechin-3-gallate (EGCG), which was a major polyphenol of green tea, against various human and animal pathogen viruses. At a concentration of 50 μM, EGCG efficiently inhibited hepatitis B virus (HBV) replication by inducing a complete autophagic process [23]. At the same concentration, EGCG inhibited hepatitis C virus (HCV) infection by more than 90% at an early stage of the viral life cycle [20]. EGCG at higher concentrations (≥100 μM) reduced ≥1,000-fold herpes simplex virus type 2 (HSV-2) titers in 10 to 20 min and reduced the same amount of HSV type 1 (HSV-1) titers in 30 to 40 min [24]. Catechins (195 μg/ml) were able to completely inhibit the synthesis of SARS-CoV antigens [25]. At a concentration of 10 g/kg feed of green tea, byproducts exhibited a significant inhibitory activity () against the H9N2 avian influenza virus (AIV) in chickens [26]. EGCG (50 μM) combined zinc sulfate and silver nanoparticles which exhibited very strong antiviral activity () against the H5N1 AIV, with a reduction in the log titer of the virus by up to 7.6 times [27]. The combination of EGCG (25 μM) and zinc sulfate exhibited strong antiviral activity () against peste des petits ruminants virus (PPRV) [28]. Wang et al. [29] found that tea polyphenols (TPPs) suppressed PRRSV load in the stages of viral attachment, internalization, replication, and release. However, none of these studies have used tea polyphenols for antiviral activity against APMV.

In this study, tea polyphenols demonstrated the inhibitory activity against NDV infection in CEF cells and chicken embryos. The concentrations, virulent strains, and drug addition times influenced the degree of compound inhibition. When polyphenon-60 was treated with cells infected with a lentogenic strain at a concentration of 50 g/ml at 0 h, significant inhibition of polyphenon-60 was observed (). Polyphenon-60 also significantly reduced () the HA titration of two lentogenic and three mesogenic NDV strains, APMV-3, and APMV-7. In in ovo experiments, polyphenon-60 at 50 μg/ml prolonged the survival period of embryos infected with mesogenic and velogenic strains. At the same concentration, it completely protected the embryos infected with the lentogenic strain from death. However, polyphenon-60 showed no inhibitory effect on four velogenic NDV strains (NDV/Niigata/85, NDV/Tokyo/96, NDV/Ibaraki-2/99, and NDV/Chiba/2001) when virucidal activity was not observed at any concentration of the compound.

Although the HA assay has been used for the quantification of viral infectious units in many studies [30–32], its sensitivity is severely limited when it is compared to real-time PCR assay [33]. The limitation of this study was using the HA assay to quantify the reduction in virus titers. However, APMV strains with four different serotypes (APMV-1, APMV-2, APMV-3, and APMV-7) and three different pathotypes (velogenic, mesogenic, and lentogenic) were tested; the HA assay was a more simple and lower-cost assay to produce the results than the real-time PCR assay. The results of the HA quantification test of 10 NDV strains could be used to compare within-group and between-groups. The results of a real-time quantitative PCR test for a single strain were used for the comparison of between-groups only. These were the reasons why the HA assay was used rather than using the real-time PCR assay in this study.

Through mediating membrane fusion, the fusion (F) protein of NDV could affect viral infection and pathogenicity [6]. The antiviral activity of polyphenon-60 was widely different among the three pathotypes of NDV. The compound exhibited strong inhibition activity against the replication of the lentogenic strain. It exhibited moderate to very weak inhibition activity against the replication of mesogenic and velogenic strains. These results suggested that polyphenon-60 inhibited virus-cell fusion by interacting with the F0 protein (avirulent strain) but not with the F protein (virulent strain). Similar results were obtained when Vero cells were infected with the avirulent NDV (LaSota) strain and were treated with fucoidan [34]. Slight inhibition was observed when CEF cells were pretreated (−1 h) with the compound before the infection of NDV. The deposition of this compound on monolayer cells might prevent viral adsorption. NDV bound to chicken RBCs through the HN binding site [35]. The results of the hemagglutination inhibition assay suggested that polyphenon-60 might bind to NDV, thereby inhibiting the HA activity of the virus.

For thousands of years, tea consumption indicates a lower risk of the toxicity in tea and tea polyphenols [36]. In this study, polyphenon-60 did not cause significant damage to CEF cells at any concentration less than 350 μg/ml, while the antiviral effective doses of the compound ranged from 50 μg/ml to 200 μg/ml. Polyphenon-60 was found to have wide safety margins.

The in ovo application of various materials in birds included vaccines, drugs, hormones, probiotics and prebiotics, peptides, carbohydrates, vitamins, and plant extracts [37]. Conventional supplementation routes such as in-feed and in-water were less economical routes than in ovo delivery of bioactive substances [38]. Moreover, many studies have used the in ovo model for the evaluation of the antiviral efficacy of herbal extracts instead of using the chicken model [27, 39, 40]. The chicken embryo is an inexpensive and efficient screening model for drug discovery [41] and a well-available in vivo animal model in the field of scientific experimentation and application [42]. However, discrepancy between the results of in ovo and chicken models might sometimes occur such as dsRNA had antiviral activity in ovo and in vitro but not in chickens after hatch [40]. The differences in routes of administration and the age of the animals might have contributed to this discrepancy. The results of this study showed the antiviral effects of polyphenon-60 in in ovo and in vitro models. Future clinical trials with chickens are necessary to support the effective use of polyphenon-60 as one medicament for poultry.

5. Conclusion

Considering newly emerging NDV and other APMVs, the use of green tea polyphenon-60 will be useful for inhibiting virus infection. The results presented in this study suggest that polyphenon-60 with inhibitory effects against APMV in in vitro and in ovo models might be developed as a potential antiviral agent that has wide safety margins. In the future, challenge studies to evaluate its efficacy in chickens will be explored.

Data Availability

All the research data used to support this study are included within the manuscript.

Conflicts of Interest

The author declares that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

The author highly acknowledges the Laboratory of Infectious Diseases, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, for providing the facilities. This work was supported by the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (ID no. P06224).

References

P. Gogoi, K. Ganar, and S. Kumar, “Avian paramyxovirus: a brief review,” Transboundary and Emerging Diseases, vol. 64, no. 1, pp. 53–67, 2017.
View at: Publisher Site | Google Scholar
M. A. Elbehairy, K. S. Khattar, and S. K. Samal, “Recovery of recombinant avian paramyxovirus type-3 strain Wisconsin by reverse genetics and its evaluation as a vaccine vector for chickens,” Viruses, vol. 13, no. 2, Article ID 316, 2021.
View at: Publisher Site | Google Scholar
K. M. Dimitrov, H. L. Ferreira, M. J. Pantin-Jackwood et al., “Pathogenicity and transmission of virulent newcastle disease virus from the 2018-2019 California outbreak and related viruses in young and adult chickens,” Virology, vol. 531, pp. 203–218, 2019.
View at: Publisher Site | Google Scholar
G. Cattoli, L. Susta, C. Terregino, and C. Brown, “Newcastle disease: a review of field recognition and current methods of laboratory detection,” Journal of Veterinary Diagnostic Investigation, vol. 23, no. 4, pp. 637–656, 2011.
View at: Publisher Site | Google Scholar
J. Jeong, Y. Kim, I. An et al., “Complete genome sequence of a novel avian paramyxovirus isolated from wild birds in South Korea,” Archives of Virology, vol. 163, no. 1, pp. 223–227, 2018.
View at: Publisher Site | Google Scholar
Y. Ji, T. Liu, Y. Jia et al., “Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens,” Virology, vol. 509, pp. 146–151, 2017.
View at: Publisher Site | Google Scholar
T. Liu, Y. Song, Y. Yang et al., “Hemagglutinin-Neuraminidase and fusion genes are determinants of NDV thermostability,” Veterinary Microbiology, vol. 228, pp. 53–60, 2019.
View at: Publisher Site | Google Scholar
P. J. Miller, R. Haddas, L. Simanov et al., “Identification of new sub-genotypes of virulent Newcastle disease virus with potential panzootic features,” Infection, Genetics and Evolution, vol. 29, pp. 216–229, 2015.
View at: Publisher Site | Google Scholar
J. Xu, Z. Xu, and W. Zheng, “A review of the antiviral role of green tea catechins,” Molecules, vol. 22, no. 8, Article ID 1337, 2017.
View at: Publisher Site | Google Scholar
N. Calland, M.-E. Sahuc, S. Belouzard et al., “Polyphenols inhibit hepatitis C virus entry by a new mechanism of action,” Journal of Virology, vol. 89, no. 19, pp. 10053–10063, 2015.
View at: Publisher Site | Google Scholar
B. M. Carneiro, M. N. Batista, A. C. S. Braga, M. L. Nogueira, and P. Rahal, “The green tea molecule EGCG inhibits Zika virus entry,” Virology, vol. 496, pp. 215–218, 2016.
View at: Publisher Site | Google Scholar
J. Gopal, M. Muthu, D. Paul, D. H. Kim, and S. Chun, “Bactericidal activity of green tea extracts: the importance of catechin containing nano particles,” Scientific Reports, vol. 6, Article ID 19710, 2016.
View at: Publisher Site | Google Scholar
W. C. Reygaert, “Green tea catechins: their use in treating and preventing infectious diseases,” BioMed Research International, vol. 2018, Article ID 9105261, 2018.
View at: Publisher Site | Google Scholar
C. Musial, A. Kuban-Jankowska, and M. Gorska-Ponikowska, “Beneficial properties of green tea catechins,” International Journal of Molecular Sciences, vol. 21, no. 5, Article ID 1744, 2020.
View at: Publisher Site | Google Scholar
A. Renzetti, J. W. Betts, K. Fukumoto, and R. N. Rutherford, “Antibacterial green tea catechins from a molecular perspective: mechanisms of action and structure-activity relationships,” Food & Function, vol. 11, no. 11, pp. 9370–9396, 2020.
View at: Publisher Site | Google Scholar
A. M. Sosa, A. Moya Álvarez, E. Bracamonte, M. Korenaga, J. D. Marco, and P. A. Barroso, “Efficacy of topical treatment with (-)-Epigallocatechin gallate, A green tea catechin, in mice with cutaneous leishmaniasis,” Molecules, vol. 25, no. 7, Article ID 1741, 2020.
View at: Publisher Site | Google Scholar
H. M. Pham, C. Nakajima, K. Ohashi, and M. Onuma, “Loop-Mediated Isothermal Amplification for rapid detection of Newcastle disease virus,” Journal of Clinical Microbiology, vol. 43, no. 4, pp. 1646–1650, 2005.
View at: Publisher Site | Google Scholar
W. Allan and R. Gough, “A standard hemagglutination inhibition test for Newcastle disease. (1). A comparison of macro and micro method,” The Veterinary Record, vol. 95, no. 6, pp. 120–123, 1974.
View at: Publisher Site | Google Scholar
L. J. Reed and H. Muench, “A simple method of estimating fifty percent endpoints,” American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938.
View at: Publisher Site | Google Scholar
N. Calland, A. Albecka, S. Belouzard et al., “(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry,” Hepatology, vol. 55, no. 3, pp. 720–729, 2012.
View at: Publisher Site | Google Scholar
D. L. Suarez, Newcastle Disease, Other Avian Paramyxoviruses, and Avian Metapneumovirus Infections, Wiley-Blackwell, Hoboken, NJ, USA, 2020, In Diseases of Poultry.
A. E. Absalón, D. V. Cortés-Espinosa, E. Lucio, P. J. Miller, and C. L. Afonso, “Epidemiology, control, and prevention of newcastle disease in endemic regions: Latin America,” Tropical Animal Health and Production, vol. 51, no. 5, pp. 1033–1048, 2019.
View at: Publisher Site | Google Scholar
L. Zhong, J. Hu, W. Shu, B. Gao, B. Gao, and S. Xiong, “Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication,” Cell Death & Disease, vol. 6, Article ID e1770, 2015.
View at: Publisher Site | Google Scholar
C. E. Isaacs, G. Y. Wen, W. Xu et al., “Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 3, pp. 962–970, 2008.
View at: Publisher Site | Google Scholar
C. C. Yang, C. J. Wu, C. Y. Chien, and C. T. Chien, “Green tea polyphenol catechins inhibit coronavirus replication and potentiate the adaptive immunity and autophagy-dependent protective mechanism to improve acute lung injury in mice,” Antioxidants, vol. 10, no. 6, Article ID 928, 2021.
View at: Publisher Site | Google Scholar
H. J. Lee, Y. N. Lee, H.-N. Youn et al., “Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens,” Poultry Science, vol. 91, no. 1, pp. 66–73, 2012.
View at: Publisher Site | Google Scholar
M. J. Saadh and S. M. Aldalaen, “Inhibitory effects of epigallocatechin gallate (EGCG) combined with zinc sulfate and silver nanoparticles on avian influenza A virus subtype H5N1,” European Review for Medical and Pharmacological Sciences, vol. 25, no. 6, pp. 2630–2636, 2021.
View at: Publisher Site | Google Scholar
M. Saadh, “Epigallocatechin gallate (EGCG) combined with zinc sulfate inhibits Peste des petits ruminants virus entry and replication,” Saudi Journal of Biological Sciences, vol. 28, no. 11, pp. 6674–6678, 2021.
View at: Publisher Site | Google Scholar
X. Wang, W. Dong, X. Zhang et al., “Antiviral mechanism of tea polyphenols against porcine reproductive and respiratory syndrome virus,” Pathogens, vol. 10, no. 2, Article ID 202, 2021.
View at: Publisher Site | Google Scholar
M. D. Hein, P. Arora, P. Marichal-Gallardo et al., “Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles,” BMC Biology, vol. 19, no. 1, Article ID 91, 2021.
View at: Publisher Site | Google Scholar
F. R. Anjum, S. U. Rahman, M. A. Aslam, and A. S. Qureshi, “Comparative study of protection against newcastle disease in young broilers administered natural chicken alpha interferon via oral and intramuscular routes,” mSphere, vol. 5, no. 4, Article ID e00585-20, 2020.
View at: Publisher Site | Google Scholar
Y. Zhang, L. Han, L. Xia, Y. Yuan, and H. Hu, “Assessment of hemagglutination activity of porcine deltacoronavirus,” Journal of Veterinary Science, vol. 21, no. 1, Article ID e12, 2020.
View at: Publisher Site | Google Scholar
M. L. Chapagain, T. Nguyen, T. Bui, S. Verma, and V. R. Nerurkar, “Comparison of real-time PCR and hemagglutination assay for quantitation of human polyomavirus JC,” Virology Journal, vol. 3, Article ID 3, 2006.
View at: Publisher Site | Google Scholar
R. Elizondo-Gonzalez, L. E. Cruz-Suarez, D. Ricque-Marie, E. Mendoza-Gamboa, C. Rodriguez-Padilla, and L. M. Trejo-Avila, “In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus,” Virology Journal, vol. 9, no. 307, 2012.
View at: Publisher Site | Google Scholar
J. Sun, Z. Han, T. Qi, R. Zhao, and S. Liu, “Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein,” Journal of Biological Chemistry, vol. 292, no. 49, pp. 20141–20161, 2017.
View at: Publisher Site | Google Scholar
K. Nakagawa, S. Okuda, and T. Miyazawa, “Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma,” Bioscience, Biotechnology, and Biochemistry, vol. 61, no. 12, pp. 1981–1985, 1997.
View at: Publisher Site | Google Scholar
E. D. Peebles, “In ovo applications in poultry: a review,” Poultry Science, vol. 97, no. 7, pp. 2322–2338, 2018.
View at: Publisher Site | Google Scholar
S. Oladokun and D. I. Adewole, “In ovo delivery of bioactive substances: an alternative to the use of antibiotic growth promoters in poultry production—a review,” Journal of Applied Poultry Research, vol. 29, no. 3, pp. 744–763, 2020.
View at: Publisher Site | Google Scholar
S. S. Ghoke, R. Sood, N. Kumar et al., “Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extracts against H9N2 virus using embryonated chicken egg model,” BMC Complementary and Alternative Medicine, vol. 18, Article ID 174, 2018.
View at: Publisher Site | Google Scholar
H. Ahmed-Hassan, M. S. Abdul-Cader, U. De Silva Senapathi et al., “Potential mediators of in ovo delivered double stranded (ds) RNA-induced innate response against low pathogenic avian influenza virus infection,” Virology Journal, vol. 15, Article ID 43, 2018.
View at: Google Scholar
S. Bjørnstad, L. P. Austdal, B. Roald, J. C. Glover, and R. E. Paulsen, “Cracking the egg: potential of the developing chicken as a model system for nonclinical safety studies of pharmaceuticals,” Journal of Pharmacology and Experimental Therapeutics, vol. 355, no. 3, pp. 386–396, 2015.
View at: Google Scholar
B. Kundeková, M. Máčajová, M. Meta, I. Čavarga, and B. Bilčík, “Chorioallantoic membrane models of various avian species: differences and applications,” Biology, vol. 10, no. 4, Article ID 301, 2021.
View at: Google Scholar

Copyright

Copyright © 2021 Hang Minh Pham. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

495

Downloads

662

Citations